"TBSF" (20%) Human Albumin Solution

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

Albumin, Quantity: 200 g/L

可用日期:

CSL Behring Australia Pty Ltd

INN（国际名称）:

Albumin

药物剂型:

Injection, solution

组成:

Excipient Ingredients: octanoate; sodium

给药途径:

Intravenous

每包单位数:

50mL, 100mL

类:

Medicine Listed (Export Only)

处方类型:

(S1) This Schedule is intentionally blank

疗效迹象:

Hypoproteinaemia in the acutely ill patient TBSF (20%) Human Albumin Solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock. TBSF (20%) Human Albumin Solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. Burns. Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

產品總結:

Visual Identification: Clear, slightly viscous almost colourless, yellow or green; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

授权状态:

Listed (Export Only)

授权日期:

2006-03-01